As with so many other conditions, in vascular health, patients often need to be seen within a few days or weeks, but current referral systems drag on for many weeks and months.

The post How Good Referral Pathways Impact Vascular and Overall Health appeared first on MedCity News.

Five ways stakeholders can promote screening and treatment for elevated Lp(a) in the future to improve overall cardiac disease mortality

The post Why Prevention-Focused Strategies Are Key appeared first on MedCity News.

Merck drug Winrevair is the first in a new class of pulmonary arterial hypertension therapies that address a key signaling pathway behind the disease. The drug comes from Merck’s $11.5 billion acquisition of Acceleron Pharma.

The post Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval appeared first on MedCity News.

Cytokinetics drug aficamten met the main goal of a pivotal test in obstructive hypertrophic cardiomyopathy. If approved, the daily pill would compete against a Bristol Myers Squibb drug projected to become a blockbuster seller.

The post Cytokinetics Heart Drug’s Trial Data Look Competitive With BMS Med Camzyos appeared first on MedCity News.

In-home provider MedArrive can now connect members of its payer customers, particularly Medicaid plans, to Heartbeat Health for virtual cardiovascular services, the companies announced Tuesday.

The post MedArrive, Heartbeat Health Team Up To Offer In-home Cardio Care appeared first on MedCity News.

A recent Elevance Health study found that long Covid patients are 2.35 times more likely to experience cardiac arrhythmia and 3.64 times more likely to experience pulmonary embolism. The study also discovered higher mortality rates among long Covid patients.

The post Elevance Health: Long Covid Patients Are at Increased Risk for Cardiovascular Problems, Mortality appeared first on MedCity News.

CardieX, a cardiovascular technology company based in both Australia and Illinois, recently acquired Blumio, a San Mateo, California-based startup focused on cardiovascular sensors. The deal will advance both companies’ vision to accurately and easily measure blood pressure without relying on the use of a cuff.

The post CardieX Acquires Blumio, Incorporates Its Wearable Blood Pressure Sensor appeared first on MedCity News.

A Cytokinetics drug in development for treating a rare heart disorder has promising Phase 2 data suggesting it could compete against a Bristol Myers Squibb drug currently under FDA review. Cytokinetics plans to advance its small molecule to Phase 3 testing by the end of this year.

The post Cytokinetics stock soars on heart drug data that sets stage for Phase 3 studies appeared first on MedCity News.

The Blue Cross Blue Shield Association recently announced its new national health equity strategy that will focus on maternal health, diabetes, cardiovascular care and mental health. The association’s first goal is to cut racial disparities in maternal health by 50% in the next five years.

The post BCBSA to take aim at racial inequities in health, starting with maternal care appeared first on MedCity News.